Effect of native vitamin D3supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of native vitamin D3supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 46, Issue 5, Pages 450-458
Publisher
Wiley
Online
2015-08-20
DOI
10.1111/hepr.12575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C
- (2015) Taeang Arai et al. JOURNAL OF MEDICAL VIROLOGY
- Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C
- (2014) Masanori Atsukawa et al. DIGESTIVE AND LIVER DISEASE
- Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis
- (2014) Mónica García-Álvarez et al. HEPATOLOGY
- Serum 25-hydroxyvitamin D3levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load
- (2014) Masanori Atsukawa et al. HEPATOLOGY RESEARCH
- Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
- (2014) Tania Mara Welzel et al. JOURNAL OF HEPATOLOGY
- Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial
- (2014) Norio Hayashi et al. JOURNAL OF HEPATOLOGY
- Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
- (2014) Jordan Feld SEMINARS IN LIVER DISEASE
- Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
- (2013) Stefan Zeuzem et al. GASTROENTEROLOGY
- Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study
- (2013) Masanori Atsukawa et al. Hepatitis Monthly
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study
- (2013) Michael W. Fried et al. HEPATOLOGY
- Impact ofIL28Bpolymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b
- (2013) Akihito Tsubota et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- HCV direct-acting antiviral agents: the best interferon-free combinations
- (2013) Raymond Schinazi et al. LIVER INTERNATIONAL
- 1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial
- (2013) Yasuteru Kondo et al. PLoS One
- Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection
- (2012) E. Cholongitas et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- 25-hydroxyvitamin D3suppresses hepatitis C virus production
- (2012) Takuya Matsumura et al. HEPATOLOGY
- Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes
- (2011) Meital Gal-Tanamy et al. HEPATOLOGY
- Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C
- (2011) Davide Bitetto et al. HEPATOLOGY
- IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
- (2011) Kazuaki Chayama et al. JOURNAL OF INFECTIOUS DISEASES
- Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients
- (2011) Akihito Tsubota et al. LIVER INTERNATIONAL
- Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients
- (2011) Saif Abu-Mouch WORLD JOURNAL OF GASTROENTEROLOGY
- Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
- (2010) Masayuki Kurosaki et al. JOURNAL OF HEPATOLOGY
- Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C
- (2010) Davide Bitetto et al. TRANSPLANT INTERNATIONAL
- Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
- (2009) Salvatore Petta et al. HEPATOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search